ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Aldurazyme®:Sanofi-Aventis (Suisse) SA
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
A16AB05 - LaronidaseATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A16 - Other Alimentary Tract and Metabolism Products
 
A16A - Other Alimentary Tract and Metabolism Products

This group comprises all products acting on the alimentary tract and metabolism which cannot be classified in the preceding groups. V03 - All other therapeutic products, should also be considered.
Nutrients are classified in V06 - General nutrients.

A16AB - Enzymes

This group includes gene therapy products resulting in the expression of specific enzymes.

A16AB05 - Laronidase
StärkeAdm.RouteNote
 P 
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home